As of 2024-10-09, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is 17.84 USD. This relative valuation is based on P/E multiples. With the latest stock price at 119.72 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -85.1%.
The range of the Relative Valuation is 11.82 - 25.08 USD.
| Range | Selected | |
| Trailing P/E multiples | 33.2x - 50.5x | 44.6x |
| Forward P/E multiples | 23.8x - 32.0x | 27.3x |
| Fair Price | 11.82 - 25.08 | 17.84 |
| Upside | -90.1% - -79.0% | -85.1% |
| Date | P/E |
| 2024-10-08 | 241.22 |
| 2024-10-07 | 237.33 |
| 2024-10-04 | 242.59 |
| 2024-10-03 | 239.28 |
| 2024-10-02 | 246.86 |
| 2024-10-01 | 246.47 |
| 2024-09-30 | 251.63 |
| 2024-09-27 | 250.91 |
| 2024-09-26 | 251.53 |
| 2024-09-25 | 251.09 |
| 2024-09-24 | 252.84 |
| 2024-09-23 | 251.43 |
| 2024-09-20 | 256.31 |
| 2024-09-19 | 256.08 |
| 2024-09-18 | 251.87 |
| 2024-09-17 | 253.24 |
| 2024-09-16 | 250.50 |
| 2024-09-13 | 251.15 |
| 2024-09-12 | 252.54 |
| 2024-09-11 | 258.68 |
| 2024-09-10 | 255.76 |
| 2024-09-09 | 257.27 |
| 2024-09-06 | 259.75 |
| 2024-09-05 | 269.52 |
| 2024-09-04 | 271.58 |
| 2024-09-03 | 272.20 |
| 2024-08-30 | 273.57 |
| 2024-08-29 | 276.54 |
| 2024-08-28 | 279.88 |
| 2024-08-27 | 283.39 |
| 2024-08-26 | 282.78 |
| 2024-08-23 | 283.20 |
| 2024-08-22 | 284.96 |
| 2024-08-21 | 289.03 |
| 2024-08-20 | 283.06 |
| 2024-08-19 | 276.60 |
| 2024-08-16 | 268.90 |
| 2024-08-15 | 268.66 |
| 2024-08-14 | 268.13 |
| 2024-08-13 | 268.90 |
| 2024-08-12 | 259.21 |
| 2024-08-09 | 252.54 |
| 2024-08-08 | 274.82 |
| 2024-08-07 | 282.20 |
| 2024-08-06 | 287.82 |
| 2024-08-05 | 283.39 |
| 2024-08-02 | 290.01 |
| 2024-08-01 | 290.16 |
| 2024-07-31 | 286.59 |
| 2024-07-30 | 288.20 |